L/S Ratio for Fetal Lung Maturity
An L/S ratio ≥2.0 reliably predicts fetal lung maturity in most pregnancies, but an L/S ratio ≥3.0 provides superior accuracy with a 95% positive predictive value for true lung maturity, particularly when phosphatidylglycerol (PG) is present. 1, 2
Interpretation of L/S Ratio Values
Standard Thresholds
- L/S ratio ≥2.0: Traditionally considered mature, with 96.7% specificity for predicting absence of respiratory distress syndrome (RDS) 1
- L/S ratio ≥3.0: Optimal threshold with 95% positive predictive value and only 5% false positive rate for predicting PG presence, which correlates with true lung maturity 2
- L/S ratio <2.0: Indicates fetal lung immaturity and high risk for RDS 3, 4
Important Caveats
The L/S ratio has a relatively high false-negative rate (73.7%), meaning immature results may not accurately predict RDS occurrence 1. However, mature results are highly reliable for predicting absence of RDS 4.
Management Based on L/S Ratio Results
When L/S Ratio is ≥2.0-2.5
- Confirm with PG testing if available, as the combination provides superior accuracy 1, 2
- If PG is present: Proceed with delivery if otherwise indicated; risk of respiratory morbidity is minimal 5
- If PG is absent or trace: Consider waiting or use L/S ratio ≥3.0 as threshold, as respiratory morbidity risk increases to 23% when PG is not present 5
When L/S Ratio is ≥3.0
- This threshold corresponds to "mature" PG results and indicates true fetal lung maturity 2
- Safe to proceed with delivery if otherwise indicated 2
When L/S Ratio is <2.0
- Delay delivery if possible to allow further lung maturation 3
- Administer antenatal corticosteroids if gestational age is 34 0/7 to 36 6/7 weeks and delivery is anticipated within 7 days 6
- For gestational age <34 weeks with anticipated preterm delivery, corticosteroids are standard of care 6
Special Populations Requiring Modified Interpretation
Diabetic Pregnancies
- L/S ratio ≥2.0 at ≥36 weeks is reliable in insulin-dependent diabetes, with only 3.9% RDS incidence (not significantly different from non-diabetic pregnancies) 7
- However, lung maturation may be delayed in some diabetic pregnancies 3
- Avoid late preterm corticosteroids (34-36 weeks) in pregestational diabetes due to increased risk of severe neonatal hypoglycemia 6
Rhesus Incompatibility
- The normal increase in L/S ratio toward term may not occur in severe rhesus disease 3
- Serial testing may be necessary to document maturity 3
Alternative and Complementary Testing
Lamellar Body Count (LBC)
- LBC >50,000 corresponds to L/S ratio >3.0 with 96% positive predictive value 2
- LBC >30,000 corresponds to L/S ratio >2.0 with 82% positive predictive value 2
- Meta-analysis shows LBC performs equally well or slightly better than L/S ratio for RDS prediction 8
Phosphatidylglycerol (PG)
- Presence of PG is the most specific indicator of lung maturity 1
- When PG is present with mature L/S ratio, there is essentially no risk of respiratory morbidity 5
- "Trace" PG should be interpreted as absent PG 2
Critical Pitfalls to Avoid
- Do not rely solely on L/S ratio 2.0-2.5 without PG confirmation when elective delivery is planned, as respiratory morbidity risk remains elevated (23%) without PG presence 5
- Do not use L/S ratio alone in diabetic pregnancies <36 weeks, as lung maturation patterns may differ 3
- Avoid contamination with blood or meconium, which can affect accuracy; if contaminated, L/S ratio may still be more reliable than other rapid tests 4
- Do not administer late preterm steroids to low-risk patients with mature lung studies, as this increases unnecessary intervention 6